In recent days, the United States Centers for Disease Control and Prevention (CDC) released alarming reports showing the development of two diseases. One produced by the fungus Candida auris and the other by the parasite Babesia microti.
In the first case, it’s a dangerous fungus whose declared cases have tripled in the past three years and more than half of states have detected it, according to a new study.
The potential for a COVID-19 pandemic has increased somewhat, according to a paper by researchers at the Centers for Disease Control and Prevention (CDC) published Monday in the Annals of Internal Medicine. He said hospital staff were under pressure from coronavirus patients, and possibly lost their focus from disinfecting other types of germs.
The Candida auris fungus spreads easily and can cause infections in wounds, ears, and the bloodstream.
The fungus, Candida auris, is a species of yeast that is usually not harmful to healthy people, but can pose a life-threatening risk to delirious patients in hospitals and nursing homes. It spreads easily and can cause infections in wounds, ears, and the bloodstream. Some strains are so-called superbugs that are resistant to all three types of antibiotics used to treat fungal infections.
It was first identified in Japan in 2009 and is now being seen more and more in other countries. The first case in the United States was in 2013, but was not reported until 2016. That year, US health officials reported 53 cases.
The new study found cases have continued to skyrocket, from 476 in 2019 to 756 in 2020 and then 1,471 in 2021. Doctors have also detected the fungus on the skin of thousands more patients, making them a risk transmission to other people.
According to WHO, Candida auris fungus is a type of unicellular pathogen “with special characteristics”. The details aren’t funny: It causes an infection in the bloodstream.
According to a cable from The Associated Press, the authors said that many of the first cases in the United States were infections brought in from abroad, but that most infections have now spread within the country.
In parallel, the Centers for Disease Control and Prevention reported in its weekly report last Friday that some places in the northeast and midwest of the country had a 25% increase between 2011 and 2019.
This condition is caused by the ‘Babesia microti’ parasite, which infects the red blood cells of humans bitten by the black-legged tick (‘Ixodes scapularis’), also known as the ‘deer tick’.
The blacklegged tick is also known as the “deer tick”. The cases of infected increased in many states of America.
Many people with babesiosis are asymptomatic, but others develop flu-like symptoms such as fever, body aches, chills, nausea, and fatigue. However, the disease can be severe and even fatal in people who have a weakened immune system or other risk factors.
The CDC documented that more than 98% of babesiosis cases were reported in the states of Connecticut, Wisconsin, Massachusetts, Minnesota, New Jersey, New York, Rhode Island, Vermont, New Hampshire, and Maine.
The public health agency considered the condition endemic in the first seven states prior to 2011, but not the last three. That’s because the infection rate in Vermont rose from 2 cases in 2011 to 34 in 2019, from 13 to 63 in New Hampshire, and from 9 to 138 in Maine.
